Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absolute Bioavailability and PK of OZ439 in Healthy Subjects
NCT04069221Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of artefenomel in malaria, sponsored by Medicines for Malaria Venture. Started Feb 2017; status: completed.
02
Drugs
artefenomel
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04069221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069221.